MedDRA Preferred Term | Placebo | BAN2401 (mg/kg) | ||||||
---|---|---|---|---|---|---|---|---|
(N = 12) (%) | 0.1 (N = 6) (%) | 0.3 (N = 6) (%) | 1 (N = 6) (%) | 3 (N = 6) (%) | 10 (N = 6) (%) | 15 (N = 6) (%) | Total (N = 36) (%) | |
Subjects with any TEAE | 8 (66.7) | 6 (100.0) | 1 (16.7) | 3 (50.0) | 3 (50.0) | 2 (33.3) | 5 (83.3) | 20 (55.6) |
Dizziness | 1 (8.3) | 2 (33.3) | 0 | 1 (16.7) | 0 | 0 | 0 | 3 (8.3) |
Fatigue | 1 (8.3) | 0 | 0 | 0 | 0 | 0 | 2 (33.3) | 2 (5.6) |
Sinusitis | 0 | 1 (16.7) | 0 | 0 | 1 (16.7) | 0 | 0 | 2 (5.6) |
Asymptomatic ARIA-H | 0 | 0 | 1 (16.7) | 1 (16.7) | 0 | 0 | 0 | 2 (5.6) |